IP Library Patent Application 11112926
Patent Application
App. No. 11/112,926

Unique sequence hybridization probes (USP)

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/112,926
Abstract

The present invention provides unique sequence probes, methods for generating them, and methods for using unique sequence probes in hybridization assays.

Claims (41)

1 . A method for preparing unique sequence probes comprising:

(a) identifying unique sequence elements contained in a nucleic acid probe, wherein the nucleic acid probe comprises a plurality of unique sequence elements and a plurality of repetitive sequence elements, and wherein the unique sequence elements in the nucleic acid probe selectively bind to a nucleic acid target of interest;

(b) amplifying unique sequence elements in the nucleic acid probe to generate amplified unique sequence elements, wherein the amplifying comprises

(i) contacting the nucleic acid probe with primer sets for a plurality of unique sequence elements under conditions to promote hybridization of the primer sets to the nucleic acid probe, wherein each primer in the plurality of primer sets has an annealing temperature of between 52° C. and 65° C., and wherein the annealing temperature for all of the primers in the plurality of primer sets are within 3° C. of each other; and

(ii) amplifying unique sequence elements defined by the primer sets in by polymerase chain reaction under conditions that comprise annealing the plurality of primer sets to the nucleic acid probe at a temperature between 51° C. and 65° C.; and

(c) pooling the amplified unique sequence elements to produce the unique sequence probe.

2 . The method of claim 1 wherein the contacting comprises contacting the nucleic acid probe with at least 10 primer sets for at least 10 unique sequence elements in the nucleic acid probe, and wherein the amplifying unique sequence elements comprises amplifying the at least 10 unique sequence elements.

3 . The method of claim 1 wherein the contacting comprises contacting the nucleic acid probe with at least 50 primer sets for at least 50 unique sequence elements in the nucleic acid probe, and wherein the amplifying unique sequence elements comprises amplifying the at least 50 unique sequence elements.

4 . The method of claim 1 further comprising labeling the unique sequence probe.

5 . The method of claim 1 wherein the contacting of the nucleic acid probe with the primer sets comprises separately contacting each individual primer set with the nucleic acid probe, and the amplifying comprises amplifying each unique sequence element in a separate polymerase chain reaction.

6 . The method of claim 5 wherein the separate polymerase chain reactions are conducted simultaneously.

7 . The method of claim 1 , further comprising placing the unique sequence probe on a solid support.

8 . A unique sequence probe made by the method of claim 1 and selected from the group consisting of:

(a) at least 50 nucleic acids selected from the group consisting of SEQ ID NOS: 893-986;

(b) at least 50 nucleic acids selected from the group consisting of SEQ ID NOS: 987-1082;

(c) at least 50 nucleic acids selected from the group consisting of SEQ ID NOS: 1083-1154;

(d) at least 50 nucleic acids selected from the group consisting of SEQ ID NOS: 1155-1242; and

(e) at least 50 nucleic acids selected from the group consisting of SEQ ID NOS: 1243-1338.

9 . A unique sequence probe selected from the group consisting of:

(a) at least 50 nucleic acids selected from the group consisting of SEQ ID NOS: 893-986;

(b) at least 50 nucleic acids selected from the group consisting of SEQ ID NOS: 987-1082;

(c) at least 50 nucleic acids selected from the group consisting of SEQ ID NOS: 1083-1154;

(d) at least 50 nucleic acids selected from the group consisting of SEQ ID NOS: 1155-1242; and

(e) at least 50 nucleic acids selected from the group consisting of SEQ ID NOS: 1243-1338.

10 . Isolated polynucleotide primer sets selected from the group consisting of

(a) at least 1 isolated polynucleotide primer set selected from polynucleotide primer sets 1-94 listed in FIG. 3 ;

(b) at least 1 isolated polynucleotide primer set selected from polynucleotide primer sets 1-96 listed in FIG. 4 ;

(c) at least 1 isolated polynucleotide primer set selected from polynucleotide primer sets 1-72 listed in FIG. 5 ;

(d) at least 1 isolated polynucleotide primer set selected from polynucleotide primer sets 1-88 listed in FIG. 6 ; and

(e) at least 1 isolated polynucleotide primer set selected from polynucleotide primer sets 1-96 listed in FIG. 7 .

11 . The isolated polynucleotide primer set of claim 10 , selected from the group consisting of

(a) at least 25 isolated polynucleotide primer set selected from polynucleotide primer sets 1-94 listed in FIG. 3 ;

(b) at least 25 isolated polynucleotide primer set selected from polynucleotide primer sets 1-96 listed in FIG. 4 ;

(c) at least 25 isolated polynucleotide primer set selected from polynucleotide primer sets 1-72 listed in FIG. 5 ;

(d) at least 25 isolated polynucleotide primer set selected from polynucleotide primer sets 1-88 listed in FIG. 6 ; and

(e) at least 25 isolated polynucleotide primer set selected from polynucleotide primer sets 1-96 listed in FIG. 7 .

12 . A kit comprising the unique sequence probe of claim 8 and instructions for its use in hybridization assays.

13 . A method for detecting a nucleic acid target of interest, comprising:

(a) generating a unique sequence probe according to the method of claim 1;

(b) contacting the unique sequence probe to a specimen to be tested under conditions to promote hybridization of the unique sequence probe to the nucleic acid target; and

(c) detecting hybridization complexes formed between the unique sequence probe and the nucleic acid target, wherein such hybridization complexes provide a measure of the nucleic acid target in the specimen.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Sep 4, 2025
From: NEW MEXICO MEZZANINE PARTERSN, L.P.; NEW MEXICO CO-INVESTMENT FUND, L.P.
To: EXAGEN INC.
Reel/Frame 072159/0497 →
SECURITY AGREEMENT Recorded Nov 4, 2010
From: EXAGEN DIAGNOSTICS, INC.
To: NEW MEXICO MEZZANINE PARTNERS, L.P.; NEW MEXICO CO-INVESTMENT FUND, L.P.
Reel/Frame 025317/0170 →
SECURITY AGREEMENT Recorded Apr 17, 2008
From: EXAGEN DIAGNOSTICS, INC.
To: TULLIS-DICKERSON CAPITAL FOCUS III, L.P.
Reel/Frame 020819/0481 →
SECURITY AGREEMENT Recorded Nov 14, 2007
From: EXAGEN DIAGNOSTICS, INC.
To: TULLIS-DICKERSON CAPITAL FOCUS III, L.P.
Reel/Frame 020111/0927 →
SECURITY AGREEMENT Recorded Feb 2, 2007
From: EXAGEN DIAGNOSTICS, INC.
To: TULLIS-DICKERSON CAPITAL FOCUS III, L.P.
Reel/Frame 018849/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2005
From: DAVIS, LISA; TANG, LEI
To: EXAGEN DIAGNOSTICS, INC
Reel/Frame 016803/0550 →